Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in analytical instruments and software serving life sciences, materials science, and food safety markets for more than 65 years. The company operates through four reportable segments following its February 2026 acquisition of Becton Dickinson's Biosciences and… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Waters Corporation does
In the company’s own words
Waters Corporation (NYSE: WAT) is a global leader in analytical instruments and software serving life sciences, materials science, and food safety markets for more than 65 years. The company operates through four reportable segments following its February 2026 acquisition of Becton Dickinson's Biosciences and Diagnostic Solutions businesses: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences.
The company's core business centers on designing, manufacturing, and servicing high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass spectrometry (MS) systems, along with complementary chromatography columns and consumable products. Waters also develops advanced software platforms that interface with its instruments and those of other manufacturers. The TA Instruments division provides thermal analysis, rheometry, and calorimetry instruments for materials characterization. The Wyatt Technology portfolio offers nanoparticle analysis and light-scattering solutions for complex biologics development.
Waters serves pharmaceutical companies, biotechnology firms, contract research organizations, chemical manufacturers, food and beverage companies, environmental testing laboratories, and academic institutions worldwide. During 2025, pharmaceutical accounts represented 59 percent of net sales, industrial accounts 30 percent, and academic and governmental institutions 11 percent. The company maintains one of the largest direct sales and service organizations in the analytical instrument industry, with 82 sales offices globally and approximately 4,300 field representatives. Services, including support plans and maintenance, represented over 35 percent of Waters segment sales and more than 25 percent of TA segment sales in 2025.
The company employs approximately 7,900 people, with 39 percent located in the United States. Manufacturing and distribution facilities are strategically located across North America, Europe, and Asia, including major centers in Milford and Taunton, Massachusetts; Wilmslow and Birmingham, England; Wexford, Ireland; and New Castle, Delaware. Waters maintains active research and development programs with approximately 1,200 employees dedicated to product innovation and enhancement.
The company's website is www.waters.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- MILFORD, MA
- Fiscal year end
- December
- CIK
- 1000697
- SIC
- 3826
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Waters Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Waters Corporation · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Waters Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Waters Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Waters Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Waters Corporation's last four quarterly filings that the numbers alone won't show?”